CASI Pharmaceuticals Inc (CASI) stock moves up, “Buy” rating reiterated by HC Wainwright Analysts

CASI Pharmaceuticals Inc (NASDAQ: CASI) shares rose on Thursday Nov 17 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, stocks opened flat this morning, struggling for direction in early trade ahead of congressional testimony by Federal Reserve Chairwoman Janet Yellen. Ahead of an appearance before the Joint Economic Committee, Yellen said an interest-rate hike could come “relatively soon,”

The S&P 500 SPX, +0.25% fell less than 0.1% to 2,176.85 while Dow Industrials DJIA, -0.05% fell 9 points to 18,858. The Nasdaq Composite COMP, +0.18% declined 0.1% to 5,291.48.

Analysts at HC Wainwright reiterated a Buy rating on shares of CASI Pharmaceuticals Inc (NASDAQ: CASI) in a reserach note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Buy on the shares, the company has a 52-week high of $1.74. The one-year price target of $3.50 is above the opening price of $1.69, that has caused a number of other analysts to comment on the company recently. Stock prices sometimes get a boost to the upside when analysts reiterate coverage.

CASI Pharmaceuticals Inc (NASDAQ: CASI) shares last traded at $1.70, which represents a jump of $0.04 or 2.41% over the previous closing price. Opening at $1.69, they varied from $1.69 and $1.70 throughout the day.

CASI Pharmaceuticals Inc (NASDAQ: CASI) now has a market cap of 102.33B.

CASI Pharmaceuticals Inc (NASDAQ: CASI) Average Daily Trading Volume

The stock’s average daily volume is 63,622 shares out of a total float 25,267,000 and some 855 shares crossed the trading desk yesterday, lower than the norm. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to pinpoint large volume aggregation or distribution by institutional investors.

As with all possible breakouts, investors look for volume to be at least 40%-50% above normal on the breakout to indicate that fund managers and other professional investors are jumping in.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have teams of analysts researching thousands of stocks, so it is good validation to see them buying a stock you’re researching.

CASI Pharmaceuticals Inc (NASDAQ: CASI) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

Traders are able to make make educated trades when they track the trading habits of professional investors.

With that in mind, CASI Pharmaceuticals Inc (NASDAQ: CASI) now has a 50-day MA of $1.37 and 200-day MA of $1.22. It has traded in a 52-week range between $0.58 – 1.74 and today’s last price is 2.30%% lower than the 52 week high of $1.74.

Earnings growth is an important factor to look at when investing in stocks and investors identify companies that have raised their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *